A One-Two Punch

Tayyaba Hasan and her colleagues developed nanocells that "combine light-based therapy with molecules" to stop cancer cells growth by limiting their supply of oxygen, reports MIT's Technology Review. The researchers enclosed the photosensitive drug verteporfin the solid polymer nanoparticles which were then, in turn, closed up in lipid particles that also contained bevacizumab, a drug that prevent blood vessel growth. The team then tested the nanocells in mice with pancreatic tumors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.